fuse: On September 27, the state organized the centralized procurement of orthopedic spine consumption materials with volume to open the bid , and announced the results of the proposed selection. Judging from the implementation results of the national spine procurement, the decline is expected to be slightly better than expected. As the wave of population aging drives continuous increase in demand, the medical device domestic leading enterprises' market concentration improvement and import substitution opportunities are worth paying attention to.
is a leading enterprise in orthopedic high-value consumables in my country, and is leading in minimally invasive surgery and dentistry. The company achieved a cumulative operating income of 828.0 million yuan in the first half of 2022, a year-on-year decrease of 2.2%; net profit attributable to shareholders was 179.9 million yuan, a year-on-year decrease of 43.3%; net profit excluding non-network profit was 144.0 million yuan, a year-on-year decrease of 49.2%. The decline in operating income is mainly caused by the epidemic and centralized procurement policies. At the same time, in the first half of the year, the company continued to increase investment in R&D, management and marketing, with period expenses increasing and short-term profits under pressure. On the premise of ensuring the quality of the company's products, the company is expected to further improve production and operation efficiency, reduce costs and increase efficiency, and provide sufficient preparations for actively responding to volume-based procurement. We look forward to its efforts in the future.
Technical preparation: the main force in the monthly line is trapped with chips
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-